Authors:
ALLAL C
SIXOU S
KRAVTZOFF R
SOULET N
SOULA G
FAVRE G
Citation: C. Allal et al., SUPRAMOLECULAR BIOVECTORS (SMBV) IMPROVE ANTISENSE INHIBITION OF ERBB-2 EXPRESSION, British Journal of Cancer, 77(9), 1998, pp. 1448-1453
Authors:
DUCHATELET IP
LANG J
SCHLUMBERGER M
VIDOR E
SOULA G
GENET A
STANDAERT SM
SALIOU P
GUEYE A
JULIEN H
LAFAIX C
LEMARDELEY P
MONNEREAU A
SPIEGEL A
SOKE M
VARICHON JP
Citation: Ip. Duchatelet et al., CLINICAL IMMUNOGENICITY AND TOLERANCE STUDIES OF LIQUID VACCINES DELIVERED BY JET-INJECTOR AND A NEW SINGLE-USE CARTRIDGE (IMULE(R)) - COMPARISON WITH STANDARD SYRINGE INJECTION, Vaccine, 15(4), 1997, pp. 449-458
Authors:
GUEDDARI N
FAVRE G
MARMOUGET C
SOULA G
LEGAILLARD F
Citation: N. Gueddari et al., INVOLVEMENT OF TYROSINE KINASE-ACTIVITY IN THE LOW-DENSITY-LIPOPROTEIN RECEPTOR EXPRESSION IN HUMAN LUNG ADENOCARCINOMA CELL-LINE A549, Biochimie, 78(10), 1996, pp. 874-881
Authors:
BERNARD J
SOULA G
VITTON O
PUCCIA J
LEBOEUF C
FIESCHI M
Citation: J. Bernard et al., TOP-FORUM - AN INTERACTIVE DATABASE TO IM PROVE THE QUALITY OF CARE IN PEDIATRIC ONCOLOGY, Bulletin du cancer, 83(11), 1996, pp. 901-909
Authors:
TOULAS C
MIHURA J
DEBALINCOURT C
MARQUES B
MAREK E
SOULA G
ROCHE H
FABRE G
Citation: C. Toulas et al., POTENTIAL PROGNOSTIC VALUE IN HUMAN BREAST-CANCER OF CYTOSOLIC NME1 PROTEIN-DETECTION USING AN ORIGINAL HEN SPECIFIC ANTIBODY, British Journal of Cancer, 73(5), 1996, pp. 630-635
Authors:
SERONIEVIVIEN S
PRADINES A
COUDERC B
CLAMAGIRAND C
BERG D
SOULA G
FAVRE G
Citation: S. Seronievivien et al., REVERSION OF TRANSFORMED PHENOTYPE OF HUMAN ADENOCARCINOMA A549 CELLSBY EXPRESSION OF 3-HYDROXY-3-METHYLGLUTARYL COENZYME-A REDUCTASE COMPLEMENTARY-DNA, Cell growth & differentiation, 6(11), 1995, pp. 1415-1425
Authors:
MEDA N
LEDRU S
FOFANA M
LANKOANDE S
SOULA G
BAZIE AJ
CHIRON JP
Citation: N. Meda et al., SEXUALLY-TRANSMITTED DISEASES AND HUMAN-IMMUNODEFICIENCY-VIRUS INFECTION AMONG WOMEN WITH GENITAL INFECTIONS IN BURKINA-FASO, International journal of STD & AIDS, 6(4), 1995, pp. 273-277
Authors:
MEDA N
SOULA G
DABIS F
COUSENS S
SOME A
MERTENS T
SALAMON R
Citation: N. Meda et al., RISK-FACTORS OF PRETERM DELIVERY AND INTR AUTERINE GROWTH-RETARDATIONIN BURKINA-FASO, Revue d'epidemiologie et de sante publique, 43(3), 1995, pp. 215-224
Authors:
TAZI KA
BONNAFOUS M
FAVRE G
SOULA G
LEGAILLARD F
Citation: Ka. Tazi et al., INVOLVEMENT OF THE CA2-DEPENDENT PHOSPHORYLATION OF A 20-KDA PROTEIN IN THE PROLIFERATIVE EFFECT OF HIGH-DENSITY-LIPOPROTEINS (SUBCLASS-3) ON THE ADENOCARCINOMA CELL-LINE A549(), Biochemical journal, 307, 1995, pp. 557-561
Citation: D. Fieschi et al., EVALUATION OF COMPUTER-ASSISTED-INSTRUCTION METHODS - AN ANALYSIS FROM 26 STUDIES FROM 1989 TO 1992, Pathologie et biologie, 42(2), 1994, pp. 183-190
Authors:
PECOUL B
VAINE F
KEITA MM
SOGA G
DJIBO A
SOULA G
ABDOU A
REY M
Citation: B. Pecoul et al., CHLORAMPHENICOL AS AN OILY SUSPENSION FOR THE TREATMENT OF BACTERIAL-MENINGITIS, Annales de pediatrie, 41(4), 1994, pp. 205-209
Authors:
LEDRU E
DIAGBOUGA S
TRANCHOTDIALLO J
CAUCHOIX B
YAMEOGO M
CHAMI D
SOULA G
CHIRON JP
Citation: E. Ledru et al., EOSINOPHILS - A PUTATIVE MARKER OF IMMUNODEPRESSION IN HIV-INFECTED AFRICAN PATIENTS WITH TUBERCULOSIS, Transactions of the Royal Society of Tropical Medicine and Hygiene, 88(1), 1994, pp. 117-118
Authors:
SERONIEVIVIEN S
COUDERC B
SOULA G
FAVRE G
Citation: S. Seronievivien et al., THE HMGCOA REDUCTASE-DNAC EXPRESSION INHI BITS THE TUMORAL PHENOTYPE OF A549 AND MCF7 HUMAN ADENOCARCINOMA CELLS, Bulletin du cancer, 81(11), 1994, pp. 962-963
Authors:
MONARDHERKT F
TEISSIERMORIER E
FAVRE G
SAMADIBABOLI M
SOULA G
HOUSSIN R
BERNIER JL
HENICHART JP
MARTINNIZARD F
FRUCHART JC
DURIEZ P
Citation: F. Monardherkt et al., INCORPORATION OF LIPOPHILIC PRODRUGS OF AMETANTRONE AND MITOXANTRONE INSIDE LOW-DENSITY LIPOPROTEINS(LDL) AND SELECTIVE UPTAKE OF THE PRODRUG LDL COMPLEX VIA THE LDL RECEPTOR PATHWAY, Acta therapeutica, 19(4), 1993, pp. 317-335
Authors:
GUEDDARI N
FAVRE G
HACHEM H
MAREK E
LEGAILLARD F
SOULA G
Citation: N. Gueddari et al., EVIDENCE FOR UP-REGULATED LOW-DENSITY-LIPOPROTEIN RECEPTOR IN HUMAN LUNG ADENOCARCINOMA CELL LINE-A549, Biochimie, 75(9), 1993, pp. 811-819
Authors:
FAVRE G
TAZI KA
LEGAILLARD F
BENNIS F
HACHEM H
SOULA G
Citation: G. Favre et al., HIGH-DENSITY LIPOPROTEIN3 BINDING-SITES ARE RELATED TO DNA BIOSYNTHESIS IN THE ADENOCARCINOMA CELL-LINE A549, Journal of lipid research, 34(7), 1993, pp. 1093-1106
Citation: F. Bennis et al., IMPORTANCE OF MEVALONATE-DERIVED PRODUCTS IN THE CONTROL OF HMG-COA REDUCTASE-ACTIVITY AND GROWTH OF HUMAN LUNG ADENOCARCINOMA CELL-LINE A549, International journal of cancer, 55(4), 1993, pp. 640-645
Authors:
PONTY E
FAVRE G
BENANIBA R
BONEU A
LUCOT H
CARTON M
SOULA G
Citation: E. Ponty et al., BIODISTRIBUTION STUDY OF TC-99M-LABELED LDL IN B16-MELANOMA-BEARING MICE - VISUALIZATION OF A PREFERENTIAL UPTAKE BY THE TUMOR, International journal of cancer, 54(3), 1993, pp. 411-417
Citation: M. Samadibaboli et al., LOW-DENSITY-LIPOPROTEIN FOR CYTOTOXIC DRUG TARGETING - IMPROVED ACTIVITY OF ELLIPTINIUM DERIVATIVE AGAINST B16 MELANOMA IN MICE, British Journal of Cancer, 68(2), 1993, pp. 319-326